Nothing wakes up an old academic institution quite like a new controversy. When a historic college of pharmacy moved to honor a leader in American homeopathy, the moment landed with all the delicacy of a mortar dropping on a marble floor. Supporters saw a tribute to entrepreneurship, multigenerational loyalty, and a niche branch of pharmacy that has managed to stay stubbornly alive in the American marketplace. Critics saw something else entirely: a scientific institution dressing up pseudoscience in ceremonial robes and calling it leadership.
That clash is what makes this story more than a campus footnote. It is really a debate about what pharmacy schools are supposed to celebrate. Is it innovation? Commercial success? Historical influence? Regulatory craftsmanship? Or should any honor tied to science be reserved for ideas and products that can survive the bright, merciless daylight of modern evidence? When the institution in question is the Philadelphia College of Pharmacy, founded in 1821 and widely recognized as the first college of pharmacy in North America, the symbolism gets even heavier. This is not some brand-new school trying to seem edgy. This is old-guard pharmacy history with portraits on the wall and a very long memory.
Editor’s note: contemporary reporting tied the honorary science degree to the college’s 188th Founders’ Day celebration in 2009, while a later obituary referenced 2008. The broader facts remain consistent: John A. “Jack” Borneman III was publicly recognized by his alma mater for his leadership in homeopathy, and the decision sparked an argument that still feels surprisingly fresh.
Why This Honor Drew So Much Attention
The headline itself practically wrote the debate. A historic college of pharmacy. A homeopathy leader. An honorary science degree. You do not need a laboratory full of analysts to predict fireworks. Contemporary accounts described John A. Borneman III as a longtime pharmacist, an industry leader, and a major figure in the Homeopathic Pharmacopeia Convention of the United States, or HPCUS. His defenders pointed to a lifetime spent developing, organizing, and standardizing homeopathic products in the United States. His critics pointed to the word science in the honorary degree and asked a fair question: if the underlying practice lacks strong scientific support, what exactly is the institution honoring?
That question mattered because honorary degrees are not neutral thank-you cards. They are symbolic statements. Universities use them to tell students, alumni, and the public: this person represents something we admire. In this case, the institution’s own justification reportedly leaned on Borneman’s entrepreneurial spirit, leadership, and willingness to share lessons with students. That may sound reasonable on paper. Plenty of universities honor founders, business builders, and public figures. But once the honoree’s career is tied to homeopathic medicine, the ceremony stops being just about leadership and starts becoming a referendum on what counts as legitimate pharmacy.
The Weight of the College’s History
The Philadelphia College of Pharmacy is not just any school with “historic” sprinkled on top like decorative parsley. It helped define pharmacy education in North America. Founded in 1821, it occupies a foundational place in the profession’s story. Over the years, the institution evolved, expanded, and eventually became part of the University of the Sciences before that university merged into Saint Joseph’s University. But the core identity remained the same: this was one of the places where modern pharmacy learned to stand up straight, wear a lab coat, and insist on standards.
That background explains the intensity of the reaction. When a newer institution does something odd, people shrug and move on. When an institution that helped build pharmacy culture does it, people read it as a message to the profession. Critics argued that honoring a homeopathy leader under a scientific banner blurred the very distinction that pharmacy education is supposed to teach: the difference between products supported by reproducible evidence and products supported mainly by tradition, belief, marketing, or regulatory quirks.
And yes, “regulatory quirks” is doing a lot of work here, but in this story it earns its paycheck.
Who Was John A. Borneman III?
John A. “Jack” Borneman III was not some random celebrity parachuted in for a ceremonial handshake and a fancy hood. He had deep roots in both the college and the homeopathic trade. Industry and family accounts describe him as part of a multigenerational line of Bornemans tied to pharmacy and homeopathy. He graduated from the Philadelphia College of Pharmacy in 1952, worked in the family business, John A. Borneman and Sons, and spent decades in homeopathic pharmacy and patient counseling.
He was also a key figure in HPCUS, the body that maintains the Homoeopathic Pharmacopoeia of the United States, or HPUS. According to industry sources, Borneman was a founding director of HPCUS in 1980 and served as its president for roughly a quarter century before later becoming chairman. To supporters, that made him a builder: a man who helped organize standards, keep a specialized sector alive, and give homeopathic products a durable regulatory infrastructure. In their telling, he was not merely selling little sugar pills with big aspirations. He was shaping a corner of American pharmacy that had historical roots, formal compendia, and a real consumer base.
That is the strongest case for the honor. Not that Borneman discovered a new therapeutic mechanism. Not that he transformed clinical evidence. But that he led, organized, and professionalized a longstanding niche within the American health marketplace.
Homeopathy’s Unusual Place in American Pharmacy
Homeopathy has always occupied a strange apartment in the building of American medicine. It is old, persistent, controversial, and somehow still not evicted. The practice dates to the late eighteenth century and is generally associated with the principle of “like cures like,” along with extreme dilution. The official U.S. homeopathic compendium, the HPUS, has a legal status that surprises many people who assume homeopathy lives entirely outside federal recognition. It does not. The HPUS is recognized under federal law, and HPCUS has maintained and published it since 1980.
That legal recognition, however, should not be confused with modern scientific endorsement. This is where casual readers often get tripped up, and where the debate around the honorary degree becomes especially important. A product can exist inside a regulatory framework and still fail to satisfy contemporary expectations for proof of safety and effectiveness. In other words, federal recognition is not the same thing as a scientific gold star. It is more like having a seat in the building, not necessarily the best argument in the room.
That distinction is now central to the homeopathy debate. Current guidance from the National Center for Complementary and Integrative Health says there is little evidence to support homeopathy as an effective treatment for any specific health condition. The FDA says no products labeled as homeopathic are FDA-approved and that such products have not been reviewed for safety and effectiveness for any disease or condition. The FTC, meanwhile, has made clear that efficacy and safety claims for over-the-counter homeopathic drugs are held to the same standard as other OTC claims, and that marketers cannot coast on tradition alone if the net impression is misleading.
What Critics Saw
Critics of the honor argued that this should have been the end of the conversation. If a college of pharmacy teaches medicinal chemistry, pharmacology, therapeutics, toxicology, and evidence-based practice, then using a science degree to honor a homeopathy leader looks like a category error in academic costume. For these critics, the problem was not merely that homeopathy remains controversial. The problem was that homeopathy’s core claims do not fit comfortably with modern pharmacologic principles. In their view, leadership in promoting an implausible therapy is not redeemed by the therapy’s commercial success or historical longevity.
Some also worried about public confusion. Consumers routinely encounter homeopathic products in chain stores, often shelved near mainstream remedies in packaging that looks every bit as polished and comforting. A university honor, especially from a famous pharmacy school, can sound like a kind of scientific blessing. Even if the institution insists it is honoring entrepreneurship rather than endorsing homeopathy itself, the symbolism can still do the endorsing all by itself. Ceremonial nuance is not exactly famous for surviving the trip from campus podium to pharmacy aisle.
What Supporters Saw
Supporters told a different story. They saw Borneman as a pharmacist, an alumnus, and a steward of a long-running American tradition. They pointed to his work with standards, his role in HPCUS, and his involvement in a regulated product category that still has loyal users. They also noted that pharmacy history is not a neat parade of perfect ideas. It is a museum full of strange bottles, dead ends, revised theories, crude formulations, plant compounds, laboratory breakthroughs, and more than a few treatments that later generations politely pretend not to remember.
From that angle, honoring Borneman was not an attempt to declare homeopathy the future of medicine. It was recognition of influence within a historically significant niche. Universities often honor people for building institutions, preserving traditions, or mentoring younger professionals. If that was the real target, supporters argued, then the award was understandable even if homeopathy itself remains hotly disputed.
Why the Story Still Matters Today
This is not just a quaint argument from the late 2000s. It still matters because the same tensions remain alive in healthcare. Consumers continue to buy homeopathic products. Federal agencies continue to warn that homeopathic products are not FDA-approved and may pose risks, particularly when quality, labeling, or vulnerable populations are involved. The FTC has already signaled that health claims must be backed by competent and reliable scientific evidence. Meanwhile, the market has been large enough for regulators to pay close attention, and survey data have shown that some Americans still self-prescribe homeopathic products, especially for colds and musculoskeletal pain.
So the honorary-degree controversy now reads like an early snapshot of a debate that never really ended. How should professional schools respond when consumer demand, market presence, historical tradition, and scientific skepticism all occupy the same shelf? Do they study the phenomenon from a critical distance? Engage it as part of history? Police it aggressively? Or celebrate the people who helped it survive? Each choice sends a message.
The Real Lesson for Pharmacy Education
The strongest takeaway is not that institutions should pretend homeopathy never existed. That would be historically silly and professionally unhelpful. Pharmacy students benefit from understanding how products enter markets, how legal frameworks outlast scientific fashions, how consumers interpret “natural” and “traditional,” and how prestige can be used to legitimize weak claims. But schools also have a responsibility to separate historical literacy from academic confusion.
A pharmacy school can teach homeopathy as history, regulation, sociology, marketing, and consumer behavior. It can examine why people buy it, why some practitioners defend it, and why regulators keep circling it. What becomes harder to defend is packaging that entire thicket inside the velvet box of a scientific honor. Once the word science is on the diploma, the institution has to expect a higher level of scrutiny. Fair or not, people will assume the honoree’s work reflects scientific achievement, not just organizational stamina.
Experiences That Surround a Story Like This
Stories like this are never experienced as abstract arguments alone. They land in real places, with real emotions, and those experiences help explain why the debate felt so charged.
For alumni, the experience can be deeply personal. Imagine spending years identifying your school with laboratory rigor, professional standards, and the evolution of pharmacy into a modern science, only to see a ceremonial spotlight aimed at a figure whose field remains one of the profession’s most polarizing subjects. Even if the institution insists it is celebrating leadership, many alumni will hear something broader. They will hear a signal about what the school believes deserves admiration. That can feel inspiring, baffling, or a little like watching your stern grandfather show up to graduation wearing novelty sunglasses.
For supporters of homeopathy, the experience looks entirely different. They may see long-overdue recognition for a tradition that has survived ridicule, regulatory battles, scientific criticism, and market competition. From that point of view, the honor validates persistence, patient demand, and a family legacy rooted in pharmacy practice. It says that homeopathy’s place in America is not just a fringe curiosity but part of a longer, more complicated healthcare story. To them, the ceremony is not a scandal. It is a correction.
For students, the experience is often educational in the best and messiest way. A controversy like this forces future pharmacists to confront how professional identity is actually built. Not in clean textbook chapters, but in arguments about standards, symbolism, law, consumer behavior, and ethics. Students get to see that scientific professions do not merely gather evidence and move forward in a straight line. They also negotiate history, institutional pride, donor culture, public messaging, and competing ideas about what leadership means. It is uncomfortable, yes, but discomfort has educated many more professionals than comfort ever did.
For consumers, the experience is usually confusion. Homeopathic products sit in mainstream retail environments with serious-looking packaging, familiar claims, and reassuring shelf placement. Many shoppers understandably assume that if a product is sold beside conventional remedies, mentioned by pharmacists, and tied to a historic college of pharmacy, then it must carry some verified medical credibility. That assumption is exactly why regulatory language matters so much. It is also why symbolic honors matter. Public trust is fragile. Once people confuse availability with proof, or tradition with evidence, the line between healthcare and hopeful branding starts to blur.
For historians of pharmacy, this whole episode feels almost inevitable. The profession has always lived in the tension between commerce and care, tradition and experiment, compounding and industrialization, patient demand and scientific correction. A historic college honoring a homeopathy leader is not an alien event dropped from space. It is a very American collision of institutional memory, entrepreneurial admiration, and unresolved questions about what the profession wants to remember fondly and what it would rather keep behind museum glass.
And maybe that is the most honest experience of all: mixed feelings. Admiration for loyalty and institutional service. Respect for history. Concern about scientific standards. Curiosity about why homeopathy still sells. Frustration that symbolic acts are never really just symbolic. This story lingers because it refuses to fit into a tidy box. It is part honor, part warning, part history lesson, and part mirror held up to pharmacy itself.
Conclusion
The decision by a historic college of pharmacy to honor a homeopathy leader was never going to pass quietly, nor should it have. The episode revealed a profession wrestling with its own values: evidence versus tradition, science versus symbolism, regulation versus endorsement, and history versus modern standards. John A. Borneman III represented more than one man’s career. He represented a durable and controversial corner of American healthcare that has managed to remain visible, legal, and commercially relevant even as scientific criticism has intensified.
That is why the story still resonates. It reminds us that professional honors are not just ceremonial flourishes. They tell the world what an institution believes is worthy of applause. And when the institution is one of pharmacy’s oldest and most respected names, every round of applause echoes a little louder.
